Glynn SE, Lanier CM, Choi AR, D'Agostino R, Farris M, Abdulhaleem M, Wang Y, Smith M, Ruiz J, Lycan T, Petty WJ, Cramer CK, Tatter SB, Laxton AW, White JJ, Su J, Whitlow CT, Soto-Pantoja DR, Xing F, Jiang Y, Chan M, Helis CA. Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases? Cancers (Basel). 2025 Mar 15; 17(6).